Jielin Sun

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Small Cell Lung Cancer

Drug Administration

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan, Haiyan Chen, Shwu-Luan Lee, Vicky Hsu, Manuela Grimstein, Nan Zheng, Jielin Sun, Rosane Charlab, Brenda J Gehrke, Jonathon Vallejo, Lori A Ehrlich, R Angelo de Claro, Marc R Theoret
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ashley C Woods, Kelly J Norsworthy, Xin Wang, Jonathon Vallejo, Edwin C Y Chow, Ruo-Jing Li, Jielin Sun, Rosane Charlab, Xiling Jiang, Richard Pazdur, Marc R Theoret, R Angelo de Claro
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Katie Chon, Erin Larkins, Somak Chatterjee, Pallavi S Mishra-Kalyani, Stephanie L Aungst, Emily Wearne, Sriram Subramaniam, Yangbing Li, Jiang Liu, Jielin Sun, Rosane Charlab, Hong Zhao, Banu Saritas-Yildirim, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Julia A Beaver, Harpreet Singh
FDA Approval Summary: Amivantamab for the Treatment of patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)